Adhesion characteristics and statistical significance analysis of different ingredients across IDDSI levels^b'*'. by Muxi Chen (9294270)

Subjects:

Hardness characteristics and statistical significance analysis of different ingredients across IDDSI levels^b'*'. by Muxi Chen (9294270)

Subjects:

Demonstration of decreased Aβ accumulation by DA-9601 treatment. by Mijung Lee (397790)

Raw data. by Jia Zhu (135506)

“…Biomechanical results revealed that the ROM of the surgical segment had decreased significantly under six basic working conditions following NZ implantation. …”

S1 Data - by Francois Kiemde (5369657)

Subjects:

Characteristic of study population. by Francois Kiemde (5369657)

Subjects:

Factors associated with the hemoglobin level stratified by age group: Linear regression. by Alejandro Rojas Chaves (20614814)

Voxel-based whole-hemisphere analysis shows regional and dose-dependent decrease of microglia. by Francesca Catto (21253435)

C2f-E improvement process. by Pingping Yan (462509)

“…Furthermore, Parameters and GFLOPs were reduced by 10.0% and 23.2%, respectively, indicating a significant enhancement in detection accuracy along with a substantial decrease in both parameters and computational costs. …”

BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. by Zahra Motahari (6814013)

Subjects:

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”

DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”

DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”

DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF by Sofia Schaeffer (20379954)

“…HC 45.4 min vs. 21.3 min, p = 0.0004), and decreased sleep efficiency (MASLD vs. HC 86.5% vs. 92.8%, p = 0.0008) compared with HC despite comparable sleep duration. …”

Literature comparison. by Saravanan Manoharan (21273304)

Subjects:

Flow chart of proposed system. by Saravanan Manoharan (21273304)

Subjects:

Literature review. by Saravanan Manoharan (21273304)

Subjects:

IMU data and video synchronization. by Saravanan Manoharan (21273304)

Subjects: